Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro
- PMID: 1734912
- DOI: 10.1002/art.1780350218
Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro
Abstract
Objective: To identify the morphology of a mineral-forming of adult porcine hyaline articular cartilage digest and characterize the mineral it forms.
Methods: Electron microscopy, Fourier transform infrared (FTIR) spectroscopy, x-ray microanalysis, compensated polarized light microscopy, and biochemical studies including 14C-labeled UDPG pyrophosphohydrolase radiometric assay.
Results: This fraction of articular cartilage digest contained membrane-limited vesicles resembling growth plate cartilage matrix vesicles and formed mineral after only 24 hours in physiologic salt solution containing 1 mM ATP: The mineral contained inorganic pyrophosphate, 95% of which derived from ATP, and phosphate, 93% of which derived from inorganic phosphate in the medium. The FTIR spectrum of this mineral closely resembled the spectrum of standard calcium pyrophosphate dihydrate (CPPD) crystals. Compensated polarized light microscopy showed positively birefringent, rod-shaped crystals morphologically identical to CPPD. Ca:P ratios, defined by energy-dispersive microanalysis, were also consistent with CPPD.
Conclusion: The articular cartilage vesicle fraction of porcine hyaline cartilage is capable of generating mineral that strongly resembles CPPD.
Similar articles
-
Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystals in vitro.J Rheumatol. 1995 Aug;22(8):1514-9. J Rheumatol. 1995. PMID: 7473476
-
Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro.Calcif Tissue Int. 1998 Sep;63(3):258-62. doi: 10.1007/s002239900523. Calcif Tissue Int. 1998. PMID: 9701631
-
Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate.J Biol Chem. 1996 Nov 8;271(45):28082-5. doi: 10.1074/jbc.271.45.28082. J Biol Chem. 1996. PMID: 8910421
-
Formation of calcium pyrophosphate crystals: biologic implications.Curr Opin Rheumatol. 2000 May;12(3):219-22. doi: 10.1097/00002281-200005000-00011. Curr Opin Rheumatol. 2000. PMID: 10803752 Review.
-
[Calcium pyrophosphate dihydrate-crystal induced arthropathy].Z Rheumatol. 2004 Feb;63(1):10-21. doi: 10.1007/s00393-004-0597-0. Z Rheumatol. 2004. PMID: 14991274 Review. German.
Cited by
-
Pathogenesis of calcium pyrophosphate crystal deposition disease.Curr Rheumatol Rep. 2001 Feb;3(1):17-23. doi: 10.1007/s11926-001-0046-x. Curr Rheumatol Rep. 2001. PMID: 11177767 Review.
-
Synovial fluid and plasma levels of cartilage matrix glycoprotein in arthritis.Calcif Tissue Int. 1994 Aug;55(2):100-2. doi: 10.1007/BF00297183. Calcif Tissue Int. 1994. PMID: 7953973 Clinical Trial.
-
Treatment and management of pseudogout: insights for the clinician.Ther Adv Musculoskelet Dis. 2012 Apr;4(2):121-31. doi: 10.1177/1759720X11432559. Ther Adv Musculoskelet Dis. 2012. PMID: 22870500 Free PMC article.
-
Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.Arthritis Rheumatol. 2018 Aug;70(8):1182-1191. doi: 10.1002/art.40517. Epub 2018 Jun 14. Arthritis Rheumatol. 2018. PMID: 29609209 Free PMC article. Review.
-
Articular cartilage vesicles and calcium crystal deposition diseases.Curr Opin Rheumatol. 2016 Mar;28(2):127-32. doi: 10.1097/BOR.0000000000000244. Curr Opin Rheumatol. 2016. PMID: 26814404 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources